Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK of [14C]-Pevonedistat in Advanced Solid Tumors
NCT03057366Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pevonedistat in solid tumor (advanced stage), sponsored by Millennium Pharmaceuticals. Primary endpoints: Maximum Observed Plasma and Whole Blood Concentration, Time to Reach Maximum Concentration and 10 more. Started May 2017; status: completed.
02
Drugs
pevonedistat
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT03057366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057366.